Uterine Cancer Clinical Trials in Boston, Massachusetts
3 recruitingBoston, Massachusetts
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab884 enrolled66 locationsNCT05579366
Recruiting
Phase 2
Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Uterine CancerUterine Serous CarcinomaUterine Carcinoma
Joyce Liu, MD25 enrolled2 locationsNCT06369155
Recruiting
Phase 2
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Ovarian CancerCervical CancerEndometrial Cancer+5 more
Dana-Farber Cancer Institute32 enrolled2 locationsNCT06677190